Insufficient scRNA-seq data for expression of FGF19 at single-cell level.
Insufficient scRNA-seq data for expression of FGF19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 19% | 3.20 | 61 / 328 | 70% | 28.75 | 124 / 178 |
liver | 32% | 39.83 | 72 / 226 | 28% | 25.73 | 114 / 406 |
intestine | 18% | 24.32 | 178 / 966 | 38% | 9.19 | 200 / 527 |
esophagus | 6% | 0.27 | 86 / 1445 | 32% | 50.22 | 59 / 183 |
breast | 31% | 3.43 | 144 / 459 | 3% | 0.23 | 30 / 1118 |
stomach | 4% | 0.25 | 14 / 359 | 24% | 7.86 | 68 / 286 |
uterus | 15% | 1.45 | 25 / 170 | 10% | 24.02 | 44 / 459 |
brain | 21% | 5.12 | 565 / 2642 | 1% | 0.07 | 6 / 705 |
ovary | 1% | 0.07 | 1 / 180 | 20% | 4.81 | 84 / 430 |
lung | 1% | 0.05 | 6 / 578 | 18% | 10.72 | 213 / 1155 |
prostate | 13% | 1.40 | 31 / 245 | 1% | 0.18 | 6 / 502 |
skin | 13% | 0.78 | 233 / 1809 | 1% | 0.04 | 4 / 472 |
bladder | 0% | 0 | 0 / 21 | 11% | 6.47 | 53 / 504 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.22 | 4 / 45 |
kidney | 3% | 0.24 | 3 / 89 | 0% | 0.10 | 4 / 901 |
adrenal gland | 2% | 0.09 | 5 / 258 | 2% | 0.36 | 4 / 230 |
adipose | 3% | 0.17 | 39 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 0.09 | 34 / 1335 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.31 | 8 / 653 | 1% | 0.10 | 7 / 605 |
heart | 1% | 0.05 | 11 / 861 | 0% | 0 | 0 / 0 |
spleen | 1% | 0.02 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.03 | 7 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.02 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0070858 | Biological process | negative regulation of bile acid biosynthetic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0030154 | Biological process | cell differentiation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0007399 | Biological process | nervous system development |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0008083 | Molecular function | growth factor activity |
GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FGF19 |
Protein name | Fibroblast growth factor 19 (FGF-19) Fibroblast growth factor (FGF) |
Synonyms | hCG_1646998 FGF8A UNQ334/PRO533 |
Description | FUNCTION: Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. Stimulates glucose uptake in adipocytes. Activity requires the presence of KLB and FGFR4. . |
Accessions | O95750 ENST00000294312.4 A0A7U3L4E7 |